Elsevier

Seminars in Perinatology

Volume 19, Issue 4, August 1995, Pages 293-300
Seminars in Perinatology

Cocaine use during pregnancy and low birth weight: The impact of prenatal care and drug treatment1

https://doi.org/10.1016/S0146-0005(05)80044-8Get rights and content

Cocaine use in pregnancy has been associated with low birth weight. Large population-based studies suggest that 5 to 7% of pregnant women have used cocaine, with much higher rates in low income inner-city women. Among 140 births at our institution of cocaine-using women, we found a lower rate of low birth weight in those who received prenatal care compared with those without prenatal care: 33 of 96 (34.3%) versus 23 of 44 (52.3%), P<.05. A review of the literature shows that comprehensive care, which includes both prenatal care and drug treatment, seems to be associated with better birth weight outcomes, particularly in women who stop their use in the first trimester. Prenatal care alone, however, is also associated with improved outcomes even if not specialized or linked to drug treatment.

References (40)

  • National Household Survey on Drug Abuse (NHSDA)
  • National Household Survey on Drug Abuse, Population Estimates 1993
  • VegaWA et al.

    Prevalence and magnitude of perinatal substance exposures in California

    N Engl J Med

    (1993)
  • Statewide prevalence of illicit drug use by pregnant women—Rhode Island

    MMWR

    (1990)
  • NewYork City Department of Health

    Vital Statistics Data

    (1992)
  • ChasnoffIJ et al.

    The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida

    N Engl J Med

    (1990)
  • OstreaEM et al.

    Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study

    Pediatrics

    (1992)
  • PhibbsG et al.

    The neonatal costs of maternal cocaine use

    JAMA

    (1991)
  • SpenceMR et al.

    The relationship between recent cocaine use and pregnancy outcome

    Obstet Gynecol

    (1991)
  • Cited by (0)

    1

    Supported by contract PHS 282-92-005 from the Agency for Health Care Policy and Research.

    View full text